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Herbal extracts targeting at the brain remain a continuous challenge to pharmacology. Usually, a number
of different animal tests have to be performed in order to ﬁnd a potential clinical use. Due to manifold
possibly active ingredients biochemical approaches are difﬁcult. A more holistic approach using a
neurophysiological technique has been developed earlier in order to characterise synthetic drugs.
Stereotactic implantation of four semi-microelectrodes into frontal cortex, hippocampus, striatum and
reticular formation of rats allowed continuous wireless monitoring of ﬁeld potentials (EEG) before and
after drug intake. After frequency analysis (Fast Fourier Transformation) electric power was calculated for
6 ranges (delta, theta, alpha1, alpha2, beta1 and beta2). Data from 14 synthetic drugs – tested earlier and
representative for different clinical indications – were taken for construction of discriminant functions
showing the projection of the frequency patterns in a six-dimensional graph. Quantitative analysis of the
EEG frequency pattern from the depth of the brain succeeded in discrimination of drug effects according
to their known clinical indication (Dimpfel and Schober, 2003). Extracts from Valerian root, Ginkgo
leaves, Paullinia seed, Hop strobile, Rhodiola rosea root and Sideritis scardica herb were tested now under
identical conditions. Classiﬁcation of these extracts based on the matrix from synthetic drugs revealed
that Valerian root and hop induced a pattern reminiscent of physiological sleep. Ginkgo and Paullinia
appeared in close neighbourhood of stimulatory drugs like caffeine or to an analgesic proﬁle (tramadol).
Rhodiola and Sideritis developed similar frequency patterns comparable to a psychostimulant drug
(methylphenidate) as well to an antidepressive drug (paroxetine).
& 2013 The Author. Published by Elsevier Ireland Ltd. Open access under CC BY-NC-ND license.1. Introduction
Characterisation of herbal extracts targeting at the brain
remains a continuous challenge to pharmacology. Usually, quite
a number of different animal tests have to be passed in order to
ﬁnd out in which direction a particular extract might act. Due to
several molecular entities or ingredients with possibly different
mechanisms of action linear dose-response relationships cannot
always be expected. Especially, on a molecular level activation or
blockade of multiple receptors by different ingredients make a
prediction of the ﬁnal drug effect nearly impossible. In addition,
prediction of a clinically useful effect based on a particular drug-
receptor action remains the exception. Therefore, biochemicallyIreland Ltd.
impfel1945@web.de
Open access under CC Bbased approaches of pharmacological characterisation of herbal
drug effects are very difﬁcult and were not really successful in the
past. However, the basic communication structure of the brain also
involves electric events, which can be measured by neurophysio-
logical techniques. Actions of neurotransmitters on the molecular
level result in changes of neuronal ion conductance. These changes
of ion conductance determine the activity pattern of a neuron
(silence, tonic ﬁring, irregular ﬁring, and burst like activity
(Turrigiano et al., 1995). According to Nase et al. (2003) this
information on neuronal and synaptic activities is contained
within ﬁeld potentials. By recording of ﬁeld potentials one can
therefore achieve information on local neuronal and synaptic
activity.
The question to be solved was: how can we quantify this
electric information content and prove the involvement of neuro-
transmitter activity. In the course of several experimental series
agonists and antagonists of particular neurotransmitter receptors
were tested by recording ﬁeld potentials from implanted semi-
microelectrodes and wireless transmission from freely moving
rats. After frequency analysis of the data by means of Fast FourierY-NC-ND license.
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4.5 Hz) were under the control of cholinergic transmission
(Dimpfel, 2005) or alpha2 waves (9.75–12.5 Hz) were changed
by compounds acting at dopaminergic transmission (Dimpfel,
2008). Frequency pattern changes of a large number of synthetic
drugs with known clinical use were fed into a discriminant
analysis and led to clustering of drugs with identical clinical use.
Using this more holistic approach drugs from 8 clinical indications
were successfully separated from each other (Dimpfel and
Schober, 2003).
The current experimental series was undertaken to test the
possibility that also herbal extracts with known or unknown
clinical proﬁles might induce changes of electric frequency pat-
terns in an analogue manner. If this is the case, herbal extracts
might be classiﬁed in the same manner, and direct comparison to
the pattern produced by synthetic drugs might give information
on future use of the extract in humans. Extracts from Valerian root
and Hop strobile represent well-known effects with respect to
improvement of sleep. Extracts from Ginkgo leaf and Paullinia
seed (Guarana) are known for their stimulatory action. These
extracts are intended to validate the experimental approach.
Extract from Rhodiola rosea root represents a newly deﬁned
pharmacological class of so-called adaptogens (Kelly, 2001).
Extract from Sideritis scardica herb has not been characterised
pharmacologically in-vivo with respect to the brain up to now.2. Material and methods
Rats were implanted with 4 bipolar concentric steel electrodes
within a stereotactic surgical procedure during anaesthesia with
Ketamine. All four electrodes were placed 3 mm lateral within the
left hemisphere. Dorso-ventral coordinates were 4, 6, 4.2 and
8 mm and anterior coordinates were 3.7, 9.7, 5.7 and 12.2 mm for
frontal cortex, striatum, hippocampus, and reticular formation,
respectively (according to the atlas of Paxinos and Watson (1982).
A pre-constructed base plate carrying 4 bipolar stainless steel
semi-micro electrodes (neurological electrodes “SNF 100” from
Rhodes Medical Instruments, Inc., Summerland, CA 93067, USA)
and a 5-pin-plug was ﬁxed to the skull by dental cement inter-
acting with 3 steel screws placed on distance into the bone. The
distant recording spot of the electrode was the active electrode
whereas the proximal spots of the four electrodes were connected
to each other to give a short circuit reference. The base plate was
carrying a plug to receive later on the transmitter (weight: 5.2 g
including battery, 26126 mm3 of size).
EEG signals were recorded from frontal cortex, hippocampus,
striatum and midbrain reticular formation of freely moving rats
from inside a totally copper shielded room. Rats were day–night
converted (12/12 h) in order to record during the active phase.
Signals were wirelessly transmitted by a radio-telemetric systemTable 1
Details on the herbal extracts used and recommended human dosages. Binomial names
Herb name Item-no. Extraction solvent Drug-extract-ratio n
Radix Valerianae ofﬁcinalis 0199368 Ethanol 35% V/V 3–6 : 1
Ginkgo biloba L. leaves 255530 Water 4.0–4.8:1
Paullinia cupana Kunth seeds 255497 Ethanol 50% w/w 6.6–8.0:1
Humulus lupulus L. 255592 Ethanol 55% w/w 18–22:1
Radix Rhodiola rosea L. 0550300 Ethanol 70% V/V 3–6:1
Herba Sideritis L. scardica 0232300 Ethanol 20% V/V 5–9:1(Rhema Labortechnik, Hofheim, Germany, using 40 Megahertz as
carrier frequency) and were ampliﬁed and processed as described
earlier to give power spectra of 0.25 Hz resolution (Dimpfel et al.,
1986, 1988, 1989). In short, after automatic artefact rejection
signals were collected in sweeps of 4 s duration and Fast Fourier
transformed using a Hanning window. Sampling frequency was
512 Hz. Four values were averaged to give a ﬁnal sampling
frequency of 128 Hz, well above the Nyquist frequency. The
resulting electrical power spectra were divided into 6 pre-
deﬁned frequency ranges (delta: 0.8–4.5 Hz; theta: 4.75–6.75 Hz;
alpha1: 7.00–9.50 Hz; alpha2: 9.75–12.50 Hz; beta1: 12.75–
18.50 Hz; beta2: 18.75–35.00 Hz). Spectra were averaged in steps
of 3 min each and displayed on-line. In an off-line procedure
spectra were averaged to give longer periods of 30 min or 1 h for
further analysis and data presentation.
Statistical evaluation was done by means of non-parametric
Wilcoxon, Mann, Whitney-Test. Linear discriminant functions
according to Fischer were taken from the results of 14 synthetic
drugs with known clinical use tested earlier under identical experi-
mental conditions. Results were depicted as six-dimensional graph
with x, y and z space representing results from ﬁrst three discrimi-
nant functions, and colour (RGB mode like in TV) representing the
next three discriminant functions. Physiological sleep was recorded
during the inactive phase of the rats.
Herbal extracts were kindly provided by the extract companies
of the Martin Bauer Group represented by Plantextrakt GmbH &
Co. KG, D 91487 Vestenbergsgreuth, Germany as well by Finzelberg
GmbH & Co. KG, D 56626 Andernach, Germany.
The characteristic of the six tested herbal extracts are listed in
Table 1. All extracts were given orally by gavage dissolved or
dispersed in water (1 ml/kg weight). Details of the extracts are
given in Table 1. Dosages were chosen by taking in account the
human dose recommendation and a relationship factor of 5–10:1
based on kilogram body weight (Shannon et al., 2007). Synthetic
drugs were administered intraperitoneally under otherwise iden-
tical experimental conditions. Administration of all preparations
were in the presence of an empty stomach. Animals were housed
in single cages with food and water ad lib. Maintenance food
(Nohrlin 10 H) was achieved from Altromin Spezialfutter GmbH &
Co. KG in 32791 Lage, Germany. Animals were held during an
inverted light–dark cycle (day¼darkness) in order to achieve
stabile recording during their active phase. The research was
conducted in accordance with the internationally accepted prin-
ciples for laboratory animal use and care as testiﬁed by authority
allowance from Regierungspräsidium Giessen, # 10 0736 540 13
00004 dated 23.02.2010.
3. Results
Extracts from Radix Valerianae and Humulus lupulus were given
during the active phase of the animals following the inactiveare given in cursive letters.
ative Content of key substances Human dose
recommended (mg)
0.1–0.2%
valerenic acids
600–900
0.8–1.2% ﬂavonoids appr. 0.4% Terpene 150–290
9–11% caffeine 100–250
0.1–0.2% 8-prenylnaringenin
NLT 4% xanthohumol
120–250
NLT 3% rosavinsNLT 1% salidroside 200–400
0.5–1.5% ﬂavonoids 0.1–0.4% caffeoylquinic acids 800–1200
Fig. 1. Comparison of changes of frequency content during sleep, plant extracts from Radix Valerianae and Humulus lupulus and the synthetic anticonvulsive drug phenytoin.
Data are given in % of a 45 min lasting pre-drug period (in the case of sleep 45 min of the active phase). Frequency ranges are depicted as coloured bar graphs on the abscissa
representing delta, theta, alpha1, alpha2, beta1 and beta2 spectral power from left to right within the four brain areas as mentioned on top of the graph.
W. Dimpfel / Journal of Ethnopharmacology 149 (2013) 583–589 585phase. Extract from Valerian root was given orally (by gavage) at a
dosage of 60 mg/kg. Despite some increases of spectral power in
the frontal cortex during the ﬁrst hour (not shown) full effect was
not seen before the second and third hour (Fig. 1, 2nd line). The
pattern as induced by this extract consisted in massive increases of
spectral power, mainly in the delta and alpha2 ranges, but also
considerably in theta and alpha1 waves. Beta1 waves increased
less and beta2 waves were not affected. Strongest effects were
seen within the frontal cortex, less in the hippocampus and even
less in striatum and reticular formation. This pattern of changes is
very reminiscent of changes observed during physiological sleep
(Fig. 1, 1st line). Clearly less and more inconsistent changes were
observed in the presence of 50 mg/kg of hop strobile (Fig. 1, 3rd
line). Again largest effects were seen in the frontal cortex. The
anticonvulsive, sedative synthetic drug phenytoin only induces
rather small increases of spectral power.
Extracts from Paullinia seed and Ginkgo leaf induced attenua-
tion of spectral power (Fig. 2). Paullinia seed at a dosage of 15 mg/
kg led to strong and in comparison to placebo statistically
signiﬁcant attenuation of alpha2 and beta1 waves. But also alpha1
waves were less signiﬁcant in frontal cortex, hippocampus and
striatum but not in the reticular formation (Fig. 2, 2nd line). The
spectral changes were nearly identical to those induced by 2.5 mg/
kg of caffeine (Fig. 2, 1st line).
Likewise aqueous Ginkgo leaf extract at a dosage of 100 mg/kg
induced signiﬁcant attenuation of alpha2 and beta1 waves in the
frontal cortex. Decrease of spectral power was also signiﬁcant in
the striatum but not in the hippocampus or reticular formation
(Fig. 2, 3rd line). In the presence of Ginkgo leaf extract also beta2waves were attenuated signiﬁcantly except for the reticular
formation. The overall pattern of changes was very similar to that
observed after administration of 2.5 mg/kg of the synthetic drug
tramadol (Fig. 2) and methylphenidate (Fig. 3).
Hydroalcoholic extract of Rhodiola rosea root at a dosage of
100 mg/kg induced statistically signiﬁcant attenuation of alpha2
and beta1 waves in all brain areas (Fig. 3, 2nd line). In addition,
spectral theta power was diminished in frontal cortex, hippocam-
pus and reticular formation. Only within the frontal cortex delta
power was attenuated. The overall pattern somewhat resembled
those changes as observed in the presence of methylphenidate
(Fig. 3) and the antidepressant synthetic drug paroxetine (Fig. 3,
4th line).
Extract of Sideritis scardica herb at a dosage of 100 mg/kg
produced spectral changes, which were similar to those observed
in the presence of Rhodiola rosea root extract at a dosage of
100 mg/kg. Again main effects were seen with regard to signiﬁcant
attenuation of alpha2 waves followed by decreases in spectral
theta power in the frontal cortex and hippocampus. Some simi-
larity was found to spectral changes seen after the administration
of 1 mg/kg paroxetine, a synthetic antidepressive drug (Fig. 3, 4th
line) and methylphenidate (Fig. 3, 1st line).
These comparisons of the effects of herbal extracts with
synthetic drugs tested under identical conditions relay on our
subjective impression. In order to get clear quantitative evaluation
of the pattern changes statistical tools are necessary. One possibi-
lity consists in using linear discriminant analysis. After having
established a set of discriminant functions on the base of earlier
testing of synthetic drugs with different clinical indications, this
Fig. 2. Comparison of extracts from Paullinia seed and Ginkgo leaf extract to synthetic drug tramadol and caffeine. Data are given in % of 45 min lasting pre-drug period. For
other details see legend to Fig. 1. Statistical signiﬁcance in comparison to control (vehicle) is documented by stars: *¼po0.05; **¼po0.01, and ***¼po0.001.
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6 herbal extracts. Twenty-four variables (6 frequency ranges times
4 brain regions) were taken for analysis. Results from the ﬁrst
three discriminant functions are depicted in space (x, y and z axis).
Next results from further 3 discriminant functions are documented
using the so-called RGB mode (additive colour mixture like used in
TV). Thus, compounds projected into close neighbourhood signa-
lise a similar clinical use. If they show the same colour their
mechanism of action seems to be in common. The result is shown
in Fig. 4.
As one can see in this projection hop strobile and Valerien root
extract position near physiological sleep. Extracts from Paullinia
seed and Ginkgo leaf are found near the synthetic drug methyl-
phenidate and caffeine. Extracts from Rhodiola rosea root and
Sideritis scardica herb are seen very close to tramadol and not too
far away from paroxetine. Thus, subjective impression of induction
of analogues spectral signatures of herbal drugs in rats in compar-
ison to the pharmacological effects of synthetic drugs is conﬁrmed
by use of discriminant analysis for statistical evaluation.4. Discussion
The holistic approach of testing drugs and herbal preparations
by using neurophysiological methods provides information on
drug effects with respect to an intermediate anatomical level.
Since it is not easily possible to follow drug-induced changes of
brain activity on a molecular level in vivo (i.e. drug-receptor
interactions), the anatomically higher integrative level of focal
ﬁeld potentials provides information half way to behaviour. Themethod has been validated by earlier testing of particular refer-
ence drugs with well-known clinical actions and ﬁled indications
to treat different diseases. This matrix of discriminant functions
produced by clinically identiﬁed drug actions has now been used
to scan for plant-derived extracts with possibly similar pharma-
cological features.
Comparison of spectral signatures of the ﬁeld potentials
recorded from the depth of the brain revealed that extracts from
Valerian root and Hop strobile induced frequency changes remi-
niscent to those observed during natural sleep. This can be
regarded as a certain piece of evidence that these extracts induce
healthy sleep. On the opposite, the effect of diazepam (and other
benzodiazepines or barbiturates tested earlier) must be regarded
more as narcotics, which – at lower dosages – induce sedation but
not healthy sleep. They also produce more unwanted side effects.
A systematic review and meta-analysis of the effects of Valerian
root extract on sleep stated that the available evidence suggests
that Valerian root extract might improve sleep quality without
producing side effects (Bent et al., 2006). This was conﬁrmed in a
newer study also in combination with hops (Dimpfel and Suter,
2008). Also for hops alone sedating effects have been described in
the literature (Schiller et al., 2006; Zanoli and Zavatti, 2008).
Further evidence for sedative effects comes from the ability of
hops to enhance pentobarbital sleep time (Zanoli et al., 2005).
Thus, positioning of valerian and hops extract in the neighbour-
hood of natural sleep suggests plausible classiﬁcation by feeding
the spectral signatures of both into discriminant analysis.
Further evidence for a meaningful classiﬁcation of herbal
preparations by quantitative measurement of ﬁeld potentials
comes from testing extracts of Paullinia seed and Ginkgo leaf
Fig. 3. Comparison of extracts from Rhodiola rosea root and Sideritis scardica herb to synthetic drugs Methylphenidate and Paroxetine. Data are given in % of 45 min lasting
pre-drug period. For other details see legend to Fig. 1. Statistical signiﬁcance in comparison to control (vehicle) is documented by stars: *¼po0.05; **¼po0.01, and
***¼po0.001.
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projection of its spectral signatures by discriminant analysis shows
Paullinia seed extract in the neighbourhood of caffeine and with
the same colour. However, the pattern of changes is not absolute
identical to that of caffeine since extract from Paullinia seed
produced stronger attenuation of alpha1 waves in the hippocam-
pus and striatum. Also, beta1 power decreased stronger in relation
to alpha2 power. Other evidence for some differences between the
effect of caffeine and Paullinia seed extract was also reported in
mouse behaviour using higher dosages of both (Campos et al.,
2005). In humans improved cognitive performance in the presence
of Paullinia seed extract was reported (Kennedy et al., 2004).
Interestingly, the spectral signature of the tested Ginkgo leaf
extract (water as extraction solvent, low enrichment of actives)
resembles very much the one observed in the presence of
methylphenidate, a drug used to treat attention-deﬁcit hyperac-
tivity disorder (ADHD). However, a double blind, randomized
clinical trial revealed that Ginkgo leaf (high enriched special
extract) was less effective in the treatment of attention-deﬁcit
hyperactivity disorder than methylphenidate (Salehi et al., 2010).
Spectral signature of Ginkgo leaf extract was also not too far away
from moclobemide, a synthetic antidepressant drug acting by
inhibition of mono-aminooxydase A. Possibly, an older report on
inhibition of monoamineoxidase by Ginkgo leaf extract relates to
this result (White et al., 1996). Another mechanism of action of
Ginkgo leaf extract possibly consists in increase of extracellular
dopamine levels (Yoshitake et al., 2010). This ﬁnding is corrobo-
rated by the fact that Ginkgo leaf extract attenuated alpha2 waveswithin all brain areas. Alpha2 waves have been shown to be
inﬂuenced by a number of different drugs acting at dopamine
receptors, which all attenuated alpha2 waves (Dimpfel, 2008).
Extracts from Rhodiola rosea root are considered to represent a
class of drugs designated as “adaptogens”. An extract from Rhodiola
rosea root has been shown to ﬁght stress-related fatigue (Olsson et al.,
2009). A pilot study also revealed effectiveness in the treatment of
generalised anxiety disorder (Bystritsky et al., 2008). Classiﬁcation by
spectral signatures of ﬁeld potentials reveals a similarity of the
frequency changes to those observed during the action of tramadol,
an analgesic drug with an opioid mechanism of action. The present
results with respect to the similarity to the effects of tramadol are in
line with a report in the literature on treatment of opioid addiction
(Mattioli et al., 2012). But paroxetine, a synthetic antidepressive drug –
sold as a serotonin reuptake inhibitor – induces similar spectral power
changes and is not far away when projected into the poly-dimensional
space by discriminant analysis which is in line with the antidepressant
activity of Rhodiola rosea extract as shown preclinically on rats
(Panossian et al., 2008) as well clinically (Darbinyan et al., 2007). So
far the classiﬁcation of these herbal preparations can be regarded as
reﬂecting the clinical use and validate this holistic approach of
pharmacological drug classiﬁcation.
Effects of extracts of Sideritis scardica herb have not been
characterised with respect to a possible action on the brain. The
currently used schedule of analysis reveals that this Sideritis scardica
herb extract might be regarded as an up to now unknown substitute
of the class of adaptogens with possible psychostimulant and
antidepressive effects. This is in accordance with in-vitro data,
Fig. 4. Comparison of different plant derived extracts to the spectral frequency patterns induced by conventional synthetic drugs with known clinical effects tested under
identical conditions by means of discriminant analysis using the “matrix” of discriminant functions established by synthetic drugs. Please note that extracts from Rhodiola
rosea root and Sideritis scardica herb position near to Tramadol, an analgesic drug, but the colour produced by Sideritis scardica herb extract goes into the direction of Ginkgo
leaf extract.
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dopamine and noradrenaline (Knörle, 2012). The similarity of the
spectral signature of Sideritis scardica herb extract to the effects of
Ginkgo leaf extract are in line with data showing enhancement of
long term potentiation in the hippocampus slice preparation in vitro
for both extracts (unpublished results). Further experiments have to
be done in order to learn more about this exciting possibility.
In summary, the holistic approach of ﬁnding spectral signatures
of telemetrically transmitted ﬁeld potentials from freely moving rats
might open the door to more speciﬁc recognition of potential use of
plant-derived preparations in humans. There is quite a bit of
evidence that analogous spectral signatures can be found in the
human EEG in the presence of psychoactive drugs (i.e. diazepam,
haloperidol) suggesting to use quantitative EEG in humans to follow
time and dose dependent actions of plant derived extracts. Clinical
results were obtained using source density EEG brain mapping with
CATEEMs in the presence of a combination of Valerian and hops
(Vonderheid-Guth et al., 2000) and a lozenge containing a mixture
of hops, lemon balm and oat (Dimpfel et al., 2004).References
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